Injectable HIV prevention treatment gets positive review

aftonbladet.se (Swedish)

A new injectable HIV prevention treatment has received a positive evaluation from the European Medicines Agency (EMA). The drug, lenakapavir, administered via injections every six months after an initial oral dose, has shown high effectiveness in preventing HIV infection in studies. This development offers a potentially easier-to-follow prevention method, aiming to reduce the global spread of HIV, which remains a significant public health concern.


With a significance score of 4.9, this news ranks in the top 1.8% of today's 30293 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: